Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Psychosocial intervention to improve cognitive and depression outcomes in older adults with mild cognitive impairment and early Alzheimer's disease

Official title: PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults With MCI and Early Stage AD

Run by Weill Medical College of Cornell University · NCT05081596 · Data updated 2026-11-12

This study is testing a new therapy to see if it can help older adults with mild cognitive impairment or early Alzheimer's disease feel better mentally and manage their pain.

More Depression trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment100 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (White Plains, New York)
StatusRecruiting
StartedJune 3, 2022
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedAugust 20, 2026
Trial IDNCT05081596 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults aged 60 and above with a diagnosis of MCI or early-stage AD, experiencing chronic pain and mild depressive symptoms.

Probably not a fit

Patients with significant suicide risk or those deemed medically or neurologically unstable may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial examines the effects of Problem Adaptation Therapy for Pain (PATH-Pain) on cognitive functioning, depression, and pain-related disability in older adults diagnosed with mild cognitive impairment (MCI) or early-stage Alzheimer's disease (AD). The study involves a randomized control trial design, where participants will receive either PATH-Pain or Attention Control Usual Care over a series of therapy sessions. The intervention consists of 8 in-office sessions followed by 6 telephone sessions, focusing on improving cognitive, affective, and functional outcomes. Assessments will be conducted at various intervals to evaluate the efficacy of the intervention.

Why it matters

Potential benefit: If successful, this intervention could significantly improve cognitive function and reduce depression and pain-related disability in older adults with MCI and early-stage AD.

How similar studies have gone: Other studies have shown promise in using psychosocial interventions for cognitive and emotional outcomes in similar populations, suggesting a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 60 years old
* MCI or early stage probable or possible AD diagnosis (as defined by Albert et al or McKhann et al) al). Patients will have at least mild cognitive deficits defined by 16 ≤ MoCA ≤ 25.
* Montgomery Asberg Depression Rating Scale (MADRS)\[55\] total ≥ 5, which reflects at least some mild depressive symptoms.
* Participants will be off antidepressants, cholinesterase inhibitors or memantine or on a stable dosage for at least 12 weeks.
* Chronic pain (neuropathic, nociceptive or mixed disorders): presence of pain on most days for at least 3 months and average pain intensity score \>=4.
* Clinical Dementia Rating 0.5 ≤ (CDR) ≤ 1.
* Participant will have capacity to consent.
* Participation of a study partner (e.g. caregiver/family member/significant other) is required.

Exclusion Criteria:

* Deemed to have a significant suicide risk as assessed by site PI and clinical team.
* Deemed too unstable medically or neurologically to safely enroll in a research trial.
* Deemed too psychiatrically unstable to safely enroll in randomized trial of psychotherapy.
* Requiring psychiatric hospitalization at baseline for safety.
* Lack of English fluency.

Where it's running

  • Weill Cornell Medicine
    White Plains, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Dimitris Kiosses, PhD — Weill Medical College of Cornell University
  • Study coordinator: Dimtiris Kiosses, PhD
  • Email: dkiosses@med.cornell.edu
  • Phone: 914-997-4381

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.